Skip to content

Comparison of the effectiveness and aesthetic result of the treatment of cherry angioma lesions with three methods of PDL vascular laser, Fractional CO2 laser and Surgical RF

Comparison of the effectiveness and aesthetic result of the treatment of cherry angioma lesions with three methods of PDL vascular laser, Fractional CO2 laser and Surgical RF

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20251019067688N1
Enrollment
10
Registered
2025-11-02
Start date
2025-11-06
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cherry angioma. Hemangioma of skin and subcutaneous tissue

Interventions

Intervention 1: At the beginning of the study, participants’ demographic information and baseline characteristics of the lesions are recorded in a predesigned questionnaire. Photographs of the treatme

Sponsors

Iran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 65 Years

Inclusion criteria

Inclusion criteria: male and female clients between the ages of 20 and 65 years in general health with at least three cherry angiomas

Exclusion criteria

Exclusion criteria: Pregnancy and breastfeeding a history of diseases that affect the body's wound healing ability (such as diabetes, connective tissue diseases, malnutrition, immunodeficiency, tendency to form keloids and hypertrophic scars, etc.) a history of taking certain medications that affect the wound healing process within the last 6 months (such as prednisolone, isotretinoin, immunosuppressant drugs, anticoagulant drugs, etc.)

Design outcomes

Primary

MeasureTime frame
Cosmetic outcome. Timepoint: One week and four weeks after treatment. Method of measurement: Dermatoscope and Visioface digital imaging.

Secondary

MeasureTime frame
Patient-perceived pain: Pain intensity of each lesion during and immediately after treatment.Adverse effects: Occurrence of erythema, inflammation, scarring, or other side effects after treatment.Time to noticeable improvement: Duration until significant lesion improvement is observed, assessed at one- and four-week follow-up visits. Timepoint: one- and four-week after treatment. Method of measurement: Patient-perceived pain: Assessed using a questionnaire during and immediately after treatment.Adverse effects: Occurrence of erythema, inflammation, scarring, or other side effects recorded.Time to noticeable improvement: Duration until significant lesion improvement, assessed at 1- and 4-week follow-ups.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMarzieh Sharifi

Iran University of Medical Sciences

dr.marziehsharifi@gmail.com+98 21 4607 8929

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026